DRUG · Unmapped registry intervention
AB801
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies
NCT06120075
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Docetaxel
Normalized identity: docetaxelView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Advanced Cancerunresolved
Interventions
AB801DRUG
DocetaxelDRUG · verified · RxNorm: docetaxel
Sponsors & collaborators
Arcus Biosciences, Inc.lead sponsor
Mapped research locations
New YorkNew York, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1AtlantaGeorgia, United States1San AntonioTexas, United States1Washington D.C.District of Columbia, United States1DenverColorado, United States1FairfaxVirginia, United States1Grand RapidsMichigan, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06120075 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.